How Should Recurrent Acute Pancreatitis Be Investigated?

Answer in brief: Recurrent acute pancreatitis should trigger a structured search for a preventable cause. Reconfirm that prior episodes met diagnostic criteria, then reassess gallstones/microlithiasis, alcohol and tobacco, triglycerides, calcium, medications and structural disease. If the initial evaluation is unrevealing, the AGA advises EUS as the preferred next diagnostic test; contrast-enhanced MRI/MRCP is a reasonable complementary or alternative study. ERCP should not be used simply to “look around” and has a limited, controversial role in unexplained recurrent pancreatitis.

Start by validating the phenotype

Patients labeled with recurrent pancreatitis sometimes have recurrent abdominal pain with nonspecific enzyme elevations rather than true recurrent acute pancreatic inflammation. Confirming the original episodes prevents an escalating cascade of invasive tests. Once recurrent acute pancreatitis is established, identify whether there is chronic pancreatitis between attacks, pancreatic duct dilation, diabetes, steatorrhea or weight loss.

Revisit common causes

Repeated history taking is worthwhile. Small gallstones and sludge can be missed, alcohol exposure may be underestimated, and medication or metabolic causes can evolve. Check fasting triglycerides when appropriate, serum calcium, liver tests and a careful drug/supplement history. Smoking independently contributes to pancreatic disease and should be addressed. In younger patients or those with a family history, genetic susceptibility may be relevant.

EUS and MRCP are complementary

After an unrevealing initial evaluation, AGA best practice advice identifies EUS as the preferred diagnostic test. EUS can detect occult biliary disease, subtle chronic pancreatitis, small tumors and ductal abnormalities. MRI with MRCP, sometimes with secretin where available, provides excellent ductal anatomy and can identify divisum, strictures and cystic lesions. The tests answer overlapping but not identical questions.

Be cautious with ERCP

The role of ERCP for preventing future attacks in pancreas divisum or unexplained recurrent pancreatitis remains controversial. Minor papilla therapy may be considered when divisum is accompanied by objective evidence of dorsal duct outflow obstruction. In normal ductal anatomy, ERCP should be considered only after a careful discussion of uncertain benefit and potentially severe adverse events.

Practical clinical algorithm

Verify that prior attacks truly represented acute pancreatitis.
Reassess gallstone disease, alcohol/tobacco, triglycerides, calcium and medication causes.
Obtain EUS after an unrevealing initial evaluation; use MRI/MRCP as a complementary or alternative test.
Consider autoimmune, genetic, neoplastic and structural causes in the appropriate phenotype.
Reserve ERCP for a defined therapeutic hypothesis after informed discussion.

Common mistakes to avoid

Calling recurrent abdominal pain “recurrent pancreatitis” without objective evidence.
Skipping a second careful biliary and medication review.
Using ERCP as a diagnostic screening test.
Ignoring smoking and genetic/familial context.
Assuming pancreas divisum is necessarily the cause of symptoms.

Trainee takeaway

In unexplained recurrent pancreatitis, EUS is usually the next best test; ERCP is a treatment decision, not a diagnostic fishing expedition.

Frequently asked questions

What test comes next after a negative initial work-up?

AGA expert guidance favors EUS; MRI/MRCP is a reasonable complementary or alternative examination.

Should everyone undergo genetic testing?

No. It is most useful in younger patients, those with a strong family history, or otherwise unexplained disease where the result may change counseling or management.

Does pancreas divisum always require ERCP?

No. Endotherapy is controversial and is mainly considered when objective outflow obstruction accompanies recurrent attacks.

Relevant free books from Dr. Thomson

Practice Review in Hepatopancreatobiliary Diseases and Nutrition — available as a free digital download from GIandHepatology.com.
Endoscopy and Diagnostic Imaging – Part II — available as a free digital download from GIandHepatology.com.

References

1. Thomson ABR. Practice Review in Hepatopancreatobiliary Diseases and Nutrition. CAPstone Academic Publishers; 2014. ISBN 978-1500855734.

2. Strand DS, Law RJ, Yang D, Elmunzer BJ. AGA Clinical Practice Update on the Endoscopic Approach to Recurrent Acute and Chronic Pancreatitis: Expert Review. Gastroenterology. 2022;163:1107-1114. doi:10.1053/j.gastro.2022.07.079.

3. Gardner TB, Adler DG, Forsmark CE, et al. ACG Clinical Guideline: Chronic Pancreatitis. Am J Gastroenterol. 2020;115:322-339.

Educational content only. Clinical decisions should incorporate the individual patient, local resources, product labeling, and the most current applicable guideline.